Transchem Ltd Stock Price Today (NSE: TRANSCHEM)

Transchem Ltd

247.00+11.75 (+4.99%)
Market Closed

Fundamental Score

...

Transchem Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Transchem Ltd share price today is 247.00, up +4.99% on NSE/BSE as of 22 June 2026. Transchem Ltd (TRANSCHEM) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 122.99 (Cr). The 52-week high for TRANSCHEM share price is 247.00 and the 52-week low is 38.31. At a P/E ratio of 32.45x, TRANSCHEM is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 6.75% and a debt-to-equity ratio of 0.00.

Transchem Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
247.00
Low
158.30
Volume
3.6K
Change
+28.55%

Transchem Ltd share price chart: 28.55% return over the past month. 52-week high ₹247.00, 52-week low ₹38.31.

Transchem Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
247.00247.00247.00247.003.09K (Cr)
235.25235.25235.25235.252.78K (Cr)
224.05224.05224.05224.052.20K (Cr)
213.40213.40201.65213.406.39K (Cr)
203.25203.25203.25203.252.68K (Cr)
193.60193.60193.60193.60681.00 (Cr)
184.40184.40184.00184.402.76K (Cr)
175.50175.65169.95175.653.83K (Cr)
167.25179.05167.25167.309.85K (Cr)
176.05183.90176.05176.058.86K (Cr)

Transchem Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
235.25247.00235.25247.00+4.99%
165.00224.05158.30224.05+35.79%
165.00189.65141.85165.00+0.00%
181.00181.00148.90162.65-10.14%
165.00184.65130.05184.65+11.91%
186.75194.25152.20170.00-8.97%
100.48183.11100.48183.11+82.24%
68.0095.7063.0195.70+40.74%
61.0174.0257.9567.42+10.51%
50.4075.8946.0161.00+21.03%
42.3052.0038.3150.05+18.32%
42.0046.0039.3542.53+1.26%

Returns & Performance

Poor

Return on Equity (ROE)

6.75%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

9.11%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Transchem Ltd Valuation Check

Poor

Price to Earnings (P/E)

32.45x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.77x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

56.45%

% shares held by company founders/management

Poor

FII Holding

0.03%

% shares held by foreign institutional investors

Poor

DII Holding

0.01%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-52.78%

Net profit growth vs same quarter last year

Revenue Growth (Quarterly YoY)

N/A

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

68.07%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

68.07%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.00x

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

18.56 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Transchem Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of TRANSCHEM across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Excellent EPS Growth (68.07% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (68.07% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Balanced Promoter Holding (56.45%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Below-Average Return on Equity (6.75%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (9.11%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Profit Decline Concern (-52.78%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Limited Institutional Interest (FII+DII: 0.04%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Transchem Ltd vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare Transchem Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
36.1/100
247
₹122.99
32.5
Average
6.75%
Poor
9.11%
Poor
0.0
Excellent
68.07%
Excellent
0.00%
65.2/100
1844
₹433738.68
37.6
Average
16.86%
Good
20.21%
Excellent
0.1
Excellent
23.78%
Excellent
9.87%
Good
0.89%
67.9/100
6798
₹170445.88
68.6
Average
15.35%
Good
20.44%
Excellent
0.0
Excellent
10.41%
Good
11.65%
Good
0.47%
65.3/100
4538
₹126430.62
58.4
Average
26.52%
Excellent
27.05%
Excellent
0.3
Excellent
13.84%
Good
7.72%
Good
0.86%
Cipla Ltd...
CIPLA500087
59/100
1418
₹123059.76
22.6
Average
17.77%
Good
22.72%
Excellent
0.0
Excellent
28.68%
Excellent
9.97%
Good
0.85%
59.2/100
1319
₹105224.96
18.2
Average
17.96%
Good
22.69%
Excellent
0.2
Excellent
22.28%
Excellent
13.26%
Good
0.63%
Lupin Ltd...
LUPIN500257
66.7/100
2276
₹95148.15
22.0
Average
20.62%
Excellent
21.30%
Excellent
0.3
Excellent
54.88%
Excellent
8.11%
Good
0.58%
68.7/100
957
₹94253.78
18.7
Average
21.21%
Excellent
24.31%
Excellent
0.4
Excellent
25.92%
Excellent
10.27%
Good
1.17%
50.6/100
2420
₹92012.53
52.6
Average
14.68%
Average
15.98%
Good
0.6
Good
11.73%
Good
15.79%
Excellent
0.04%
28.8/100
1436
₹70798.69
20.7
Average
11.08%
Average
14.18%
Average
0.2
Excellent
3.87%
Average
6.55%
Good
0.33%
59.5/100
5452
₹67075.29
28.5
Average
19.39%
Good
20.38%
Excellent
0.2
Excellent
13.93%
Good
9.21%
Good
0.80%

Transchem Ltd PE Ratio History

Historical price-to-earnings ratio for TRANSCHEM — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20254.27₹183.1142.9x
FY 20243.43₹51.4815x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Transchem Ltd Quarterly Performance

Latest quarterly metrics for TRANSCHEM — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

N/A

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-52.78%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

68.07%

Compounded annual net profit growth over 5 years

Transchem Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for TRANSCHEM — calculated from daily price history

65RSI 14
Neutral — RSI 65

Momentum is balanced — neither overbought nor oversold.

SMA 50
170
▲ Price above SMA 50 — Short-term bullish
SMA 200
124
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
3K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Transchem Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Transchem Ltd (TRANSCHEM) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Transchem Ltd

About TRANSCHEM (Transchem Ltd)

Transchem Ltd is a dynamic, research-driven pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies. We are focused on address...ing unmet medical needs in key therapeutic areas such as oncology, immunology, and central nervous system disorders. Our state-of-the-art research facilities and collaborative partnerships with leading academic institutions and biotech firms enable us to push the boundaries of pharmaceutical science. We pride ourselves on a commitment to scientific excellence, ethical practices, and patient-centricity, striving to improve the lives of individuals worldwide through the power of transformative medicines. Transchem's pipeline encompasses a diverse portfolio of novel drug candidates, from early-stage preclinical assets to late-stage clinical programs. At Transchem, we are driven by a passionate team of scientists, clinicians, and business professionals with a shared vision of creating breakthrough pharmaceuticals. Our core values are rooted in integrity, innovation, and collaboration, fostering a culture where creativity thrives and every individual is empowered to make a meaningful contribution. We maintain a strong focus on precision medicine, leveraging advanced technologies like genomics and bioinformatics to tailor treatments to individual patient profiles. This approach allows us to maximize therapeutic efficacy and minimize adverse effects. Furthermore, we are committed to sustainable and responsible practices throughout our operations, minimizing our environmental impact and supporting the communities we serve. TRANSCHEM actively seeks strategic alliances and licensing opportunities to expand our product portfolio and accelerate the delivery of novel therapies to patients. Our experienced business development team is dedicated to identifying and evaluating promising drug candidates and technologies that align with our strategic priorities. We are committed to building long-term, mutually beneficial partnerships with other pharmaceutical companies, biotech firms, and academic institutions. By combining our expertise and resources, we can collectively address the most pressing healthcare challenges and improve patient outcomes globally. TRANSCHEM is poised to emerge as a leader in the pharmaceutical industry, driven by our unwavering commitment to innovation, patient care, and global health.

Company Details

Symbol:TRANSCHEM
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Mahesh Suresh Rananavre
Whole Time Director
Ms. Sarita Maharao
Chief Financial Officer
Ms. Neeraja Deepak Karandikar
Compliance Officer & Company Secretary

TRANSCHEM Share Price: Frequently Asked Questions

What is the current share price of Transchem Ltd?

Transchem Ltd (TRANSCHEM) trades at ₹247.00 on NSE and BSE. Market cap ₹122.99 (Cr). Educational data only.

What is the P/E ratio of Transchem Ltd?

Transchem Ltd has a P/E of 32.45x vs industry average 31.77x.

What is the Bull Run score for Transchem Ltd?

Transchem Ltd has a Bull Run score of 36.1/100 based on 25+ financial parameters.

Does Transchem Ltd pay dividends?

Transchem Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Transchem Ltd?

Transchem Ltd has ROE of 6.75%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Transchem Ltd?

Transchem Ltd has debt-to-equity of 0.00.

Is Transchem Ltd a good investment?

Bull Run gives Transchem Ltd a score of 36.1/100. This is not investment advice — consult a SEBI-registered advisor.